Try it
Pharmacology · CNS drugs and antiepileptics: Dravet syndrome
Sample itemAn 8-month-old develops prolonged febrile hemiclonic seizures, later myoclonic seizures and ataxia, and genetic testing shows an SCN1A mutation. Seizures worsened after carbamazepine. Which add-on agent is appropriate?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Stiripentol
SCN1A loss of function in Dravet syndrome means sodium channel blockers such as carbamazepine, phenytoin, lamotrigine and oxcarbazepine can worsen seizures. Stiripentol, used with valproate and clobazam, and cannabidiol are effective add-on agents. Valproate and clobazam form the usual base.
Option by option
A. Phenytoin
Phenytoin blocks sodium channels and can worsen seizures in this condition.
B. Stiripentol (correct)
Correct. Stiripentol is an effective add-on to valproate and clobazam in this syndrome.
C. Lamotrigine
Lamotrigine blocks sodium channels and can aggravate seizures in Dravet syndrome.
D. Oxcarbazepine
Oxcarbazepine is a sodium channel blocker and is expected to aggravate seizures.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?